The delivery of insulin through nanocarriers is of particular significance due to its ability to provide a more convenient, secure, and non-invasive approach to administering insulin, ultimately overcoming challenges such as insulin resistance in the management of diabetes. The gene discussed is INS; the disease is diabetes mellitus.